455593536	455593536	CD	B-NP	O
|	|	NN	I-NP	O
DH	DH	NN	I-NP	O
|	|	NN	I-NP	O
70754750	70754750	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6851132	6851132	CD	B-NP	O
|	|	CC	I-NP	O
3/9/2006	3/9/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/14/2006	4/14/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
BOTTRELL	BOTTRELL	NNP	B-NP	O
,	,	,	O	O
DALE	DALE	NNP	B-NP	O
GREGORIO	GREGORIO	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Urinary	Urinary	JJ	B-NP	O
retention	retention	NN	I-NP	O
and	and	CC	I-NP	O
leg	leg	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Urinary	Urinary	JJ	B-NP	O
retention	retention	NN	I-NP	O
and	and	CC	I-NP	O
leg	leg	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Woolridge	Woolridge	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
48-year-old	48-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
bipolar	bipolar	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
antiphospholipid	antiphospholipid	JJ	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
URI	URI	NN	I-NP	O
five	five	CD	B-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
that	that	WDT	B-NP	O
developed	develop	VBD	B-VP	O
to	to	TO	B-PP	O
sinusitis	sinusitis	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
ENT	ENT	JJ	I-NP	O
visits	visit	NNS	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
noticed	notice	VBN	I-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
also	also	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
decrease	decrease	NN	B-NP	O
in	in	IN	B-PP	O
appetite	appetite	NN	B-NP	O
and	and	CC	O	O
generalized	generalize	VBN	B-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
Orthopedics	Orthopedic	NNS	B-NP	O
prior	prior	JJ	B-ADJP	O
with	with	IN	B-PP	O
full	full	JJ	B-NP	O
workup	workup	NN	I-NP	O
which	which	WDT	B-NP	O
on	on	IN	B-PP	O
diagnosis	diagnosis	NN	B-NP	O
no	no	DT	B-NP	O
fracture	fracture	NN	I-NP	O
evident	evident	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
calf	calf	NN	B-NP	O
pain	pain	NN	I-NP	O
so	so	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
and	and	CC	I-NP	O
LENIS	LENIS	NN	I-NP	B-protein
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
clots	clot	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
presented	present	VBD	B-VP	O
also	also	RB	I-VP	O
expressing	express	VBG	I-VP	O
concern	concern	NN	B-NP	O
of	of	IN	B-PP	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
void	void	VB	I-VP	O
with	with	IN	B-PP	O
suprapubic	suprapubic	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

Foley	Foley	NNP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
and	and	CC	O	O
removed	remove	VBN	B-VP	O
1	1	CD	B-NP	O
liter	liter	NN	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Antiphospholipid	Antiphospholipid	JJ	B-NP	O
antibody	antibody	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
MCA	MCA	NNP	I-NP	O
stroke	stroke	VBD	B-VP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
bipolar	bipolar	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
in	in	IN	B-PP	O
5/22	5/22	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
gout	gout	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Depakote	Depakote	NNP	B-NP	O
extended	extend	VBD	B-VP	O
release	release	NN	B-NP	O
1500	1500	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Effexor	Effexor	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Lamictal	Lamictal	JJ	B-NP	B-protein
50	50	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Magnesium	Magnesium	NN	B-NP	B-protein
oxide	oxide	NN	I-NP	I-protein
400	400	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	B-protein
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Glipizide	Glipizide	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
4-6	4-6	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
,	,	,	O	O
titrate	titrate	NN	B-NP	O
to	to	TO	B-PP	O
INR	INR	NN	B-NP	O
2-3	2-3	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Toprol-XL	Toprol-XL	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Pravachol	Pravachol	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
intolerant	intolerant	JJ	B-ADJP	O
to	to	TO	B-PP	O
Tegretol	Tegretol	NN	B-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
erythromycin	erythromycin	NN	B-NP	O
,	,	,	O	O
unclear	unclear	JJ	B-ADJP	O
what	what	WP	B-NP	O
the	the	DT	B-NP	O
reaction	reaction	NN	I-NP	O
is	be	VBZ	B-VP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
great	great	JJ	I-NP	O
aunt	aunt	NN	I-NP	O
with	with	IN	B-PP	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypercoagulable	hypercoagulable	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
family	family	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
or	or	CC	I-VP	O
drink	drink	VB	I-VP	O
or	or	CC	I-VP	O
use	use	VB	I-VP	O
IV	IV	CD	B-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
mother	mother	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-NP	O
96.6	96.6	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
112	112	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
161/82	161/82	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
awake	awake	JJ	B-ADJP	O
,	,	,	O	O
alert	alert	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
flat	flat	JJ	I-NP	O
affect	affect	NN	I-NP	O
with	with	IN	B-PP	O
slow	slow	JJ	B-NP	O
responses	response	NNS	I-NP	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
eye	eye	NN	I-NP	O
contact	contact	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x2	x2	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
without	without	IN	B-PP	O
knowing	know	VBG	B-VP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pupils	pupil	NNS	I-NP	O
are	be	VBP	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
.	.	.	O	O

Mucous	Mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
are	be	VBP	B-VP	O
dry	dry	JJ	B-ADJP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
thyromegaly	thyromegaly	RB	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
was	be	VBD	B-VP	O
tachycardic	tachycardic	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
obese	obese	JJ	B-ADJP	O
with	with	IN	B-PP	O
bowel	bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
suprapubic	suprapubic	JJ	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
and	and	CC	I-NP	O
PT	PT	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
;	;	:	O	O
his	his	PRP$	B-NP	O
neurologic	neurologic	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
slight	slight	JJ	B-NP	O
dry	dry	JJ	I-NP	O
blood	blood	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
rectal	rectal	JJ	I-NP	O
exam	exam	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
boggy	boggy	JJ	I-NP	O
prostate	prostate	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
rectal	rectal	JJ	I-NP	O
tone	tone	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
43	43	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
322	322	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.6	4.6	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
0.9	0.9	CD	I-NP	I-protein
,	,	,	O	O
TSH	TSH	NN	B-NP	B-protein
3.8	3.8	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
6.7	6.7	CD	I-NP	I-protein
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.8	9.8	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.4	1.4	CD	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
gravity	gravity	NN	I-NP	O
of	of	IN	B-PP	O
1.025	1.025	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
ketone	ketone	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
48-year-old	48-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
bipolar	bipolar	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
supratherapeutic	supratherapeutic	JJ	B-NP	O
INR	INR	NN	I-NP	O
and	and	CC	O	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
retention	retention	NN	I-NP	O
.	.	.	O	O

Genitourinary	Genitourinary	JJ	B-ADJP	O
:	:	:	O	O
Given	Give	VBN	B-VP	O
his	his	PRP$	B-NP	O
prostate	prostate	NN	I-NP	O
exam	exam	NN	I-NP	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
BPH	BPH	NN	B-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
retention	retention	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
prostate	prostate	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
taking	take	VBG	B-VP	O
opiates	opiate	NNS	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
potentially	potentially	RB	B-VP	O
also	also	RB	I-VP	O
contributing	contribute	VBG	I-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
psychiatric	psychiatric	JJ	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
voiding	void	VBG	I-NP	O
trial	trial	NN	I-NP	O
after	after	IN	B-PP	O
starting	start	VBG	B-VP	O
Flomax	Flomax	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
in	in	IN	B-PP	O
since	since	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
pain	pain	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
noninvasive	noninvasive	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
cords	cord	NNS	I-NP	O
palpated	palpate	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
prior	prior	RB	B-ADVP	O
a	a	DT	B-NP	O
orthopaedic	orthopaedic	JJ	I-NP	O
workup	workup	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
receiving	receive	VBG	I-VP	O
oxycodone	oxycodone	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
some	some	DT	B-NP	O
thought	think	VBD	B-VP	O
that	that	IN	B-SBAR	O
maybe	maybe	RB	B-ADVP	O
his	his	PRP$	B-NP	O
hypomagnesemia	hypomagnesemia	NN	I-NP	O
is	be	VBZ	B-VP	O
exacerbating	exacerbate	VBG	I-VP	O
his	his	PRP$	B-NP	O
pain	pain	NN	I-NP	O
possibly	possibly	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
leg	leg	NN	B-NP	O
cramps	cramp	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
repleted	replete	VBN	I-VP	O
with	with	IN	B-PP	O
mag	mag	NN	B-NP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
standing	stand	VBG	B-VP	O
magnesium	magnesium	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
exam	exam	NN	B-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
diabetic	diabetic	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Neurontin	Neurontin	NN	B-NP	B-protein
300	300	CD	B-NP	I-protein
qhs	qh	NNS	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	B-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
diabetic	diabetic	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
NPH	NPH	NN	B-NP	O
and	and	CC	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
reinstituted	reinstitute	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
5	5	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Anticoagulation	Anticoagulation	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
antiphospholipid	antiphospholipid	JJ	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
stroke	stroke	NN	B-NP	O
from	from	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
clot	clot	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
supratherapeutic	supratherapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
,	,	,	O	O
upon	upon	IN	B-PP	O
arrival	arrival	NN	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
reversed	reverse	VBN	I-VP	O
with	with	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
K	K	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
being	be	VBG	B-VP	O
bridged	bridge	VBN	I-VP	O
with	with	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
until	until	IN	B-PP	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
INRs	INR	NNS	B-NP	B-protein
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
checked	check	VBN	I-VP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
until	until	IN	B-PP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
2-3	2-3	NN	I-NP	I-protein
.	.	.	O	O

Psychiatric	Psychiatric	JJ	B-ADJP	O
:	:	:	O	O
For	For	IN	B-PP	O
his	his	PRP$	B-NP	O
bipolar	bipolar	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
and	and	CC	I-NP	O
seizure	seizure	NN	I-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
brief	brief	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
delirium	delirium	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
weekend	weekend	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	I-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
metabolic	metabolic	JJ	B-ADJP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
now	now	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
avoid	avoid	VB	I-VP	O
opiates	opiate	NNS	B-NP	O
when	when	WRB	B-ADVP	O
possible	possible	JJ	B-ADJP	O
.	.	.	O	O

Disposition	Disposition	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
home	home	VB	I-VP	O
on	on	IN	B-PP	O
new	new	JJ	B-NP	O
medications	medication	NNS	I-NP	O
which	which	WDT	B-NP	O
include	include	VBP	B-VP	O
increased	increase	VBN	B-NP	O
magnesium	magnesium	NN	I-NP	O
,	,	,	O	O
flomax	flomax	NN	B-NP	O
,	,	,	O	O
neurontin	neurontin	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
his	his	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
sinusitis	sinusitis	NN	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
finished	finish	VBN	I-VP	O
on	on	IN	B-PP	O
5/15/06	5/15/06	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Citracal	Citracal	JJ	B-NP	O
950	950	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Colchicine	Colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Magnesium	Magnesium	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Ocean	Ocean	JJ	B-NP	O
nasal	nasal	JJ	I-NP	O
spray	spray	NN	I-NP	O
two	two	CD	B-NP	O
sprays	spray	NNS	I-NP	O
nasally	nasally	RB	B-ADVP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Thiamine	Thiamine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
titrate	titrate	VB	B-VP	O
Coumadin	Coumadin	NNP	B-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-PP	O
INR	INR	NN	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
2-3	2-3	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Lovenox	Lovenox	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
until	until	IN	B-SBAR	O
INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
2	2	CD	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

KCl	KCl	NN	B-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Flonase	Flonase	NN	B-NP	O
two	two	CD	B-NP	O
sprays	spray	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Lamictal	Lamictal	JJ	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Augmentin	Augmentin	IN	B-PP	O
875/125	875/125	CD	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
course	course	NN	B-NP	O
dictated	dictate	VBN	B-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
ENT	ENT	NN	I-NP	O
physicians	physician	NNS	I-NP	O
to	to	TO	B-VP	O
end	end	VB	I-VP	O
on	on	IN	B-PP	O
10/23/06	10/23/06	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
for	for	IN	B-PP	O
sinusitis	sinusitis	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Effexor	Effexor	NN	B-NP	O
extended	extend	VBD	B-VP	O
release	release	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

Depakote	Depakote	NNP	B-NP	O
extended	extend	VBD	B-VP	O
release	release	NN	B-NP	O
1500	1500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

21	21	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

22	22	CD	B-NP	O
.	.	.	O	O

Glipizide	Glipizide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
23	23	CD	I-NP	O
.	.	.	O	O

Magnesium	Magnesium	NN	B-NP	O
oxide	oxide	NN	I-NP	O
1600	1600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
24	24	CD	I-NP	O
.	.	.	O	O

Metformin	Metformin	NN	B-NP	O
850	850	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
ADDENDUM	ADDENDUM	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	O	O
ENT	ENT	NN	B-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-0424312	3-0424312	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
RHYME	RHYME	NNP	B-NP	O
,	,	,	O	O
ZACKARY	ZACKARY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
RAPPAPORT	RAPPAPORT	NN	B-NP	O
,	,	,	O	O
ARTURO	ARTURO	NN	B-NP	O
OMAR	OMAR	NN	I-NP	O
Dictation	Dictation	NN	I-NP	O
ID	ID	NN	I-NP	O
7085205	7085205	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/16/06	10/16/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/16/06	10/16/06	CD	B-NP	O

